Francesca Colonese

542 total citations
24 papers, 367 citations indexed

About

Francesca Colonese is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Francesca Colonese has authored 24 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Francesca Colonese's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (7 papers). Francesca Colonese is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Lung Cancer Research Studies (7 papers). Francesca Colonese collaborates with scholars based in Italy, Switzerland and United States. Francesca Colonese's co-authors include Diego Cortinovis, Stefania Canova, Roberta Granese, Onofrio Triolo, Antonio Simone Laganà, Vincenza Sofo, Francesca Maria Salmeri, Panagiotis Paliogiannis, Carlo Putzu and Ciriaco Carru and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Journal of Cellular Physiology.

In The Last Decade

Francesca Colonese

21 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Colonese Italy 10 171 92 85 64 61 24 367
Geoffrey Otton Australia 12 114 0.7× 84 0.9× 38 0.4× 108 1.7× 50 0.8× 20 397
Andrea Wahner Hendrickson United States 8 146 0.9× 61 0.7× 64 0.8× 79 1.2× 27 0.4× 17 293
Xiaojie Fang China 12 115 0.7× 54 0.6× 38 0.4× 63 1.0× 112 1.8× 52 329
José Luis Alonso-Romero Spain 14 227 1.3× 69 0.8× 121 1.4× 77 1.2× 32 0.5× 47 517
Tomoko Hirakawa Japan 12 95 0.6× 158 1.7× 61 0.7× 73 1.1× 35 0.6× 30 467
Giusi Santangelo Italy 11 119 0.7× 90 1.0× 28 0.3× 59 0.9× 39 0.6× 37 369
Mary M. Mullen United States 11 136 0.8× 66 0.7× 22 0.3× 72 1.1× 15 0.2× 29 274
Emily Prendergast United States 10 78 0.5× 109 1.2× 40 0.5× 127 2.0× 37 0.6× 29 326
Tashanna Myers United States 11 117 0.7× 239 2.6× 33 0.4× 41 0.6× 39 0.6× 29 385

Countries citing papers authored by Francesca Colonese

Since Specialization
Citations

This map shows the geographic impact of Francesca Colonese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Colonese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Colonese more than expected).

Fields of papers citing papers by Francesca Colonese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Colonese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Colonese. The network helps show where Francesca Colonese may publish in the future.

Co-authorship network of co-authors of Francesca Colonese

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Colonese. A scholar is included among the top collaborators of Francesca Colonese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Colonese. Francesca Colonese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avancini, Alice, Niccolò Giaj‐Levra, Gabriele Minuti, et al.. (2025). Current diagnostic and therapeutical approaches to bone metastases in patients with non-small cell lung cancer: A cross-sectional study. Lung Cancer. 203. 108531–108531.
2.
Canova, Stefania, et al.. (2025). The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer. Discover Oncology. 16(1). 100–100. 1 indexed citations
3.
Cordani, Nicoletta, et al.. (2024). Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 25(20). 11214–11214. 5 indexed citations
4.
Ceresoli, Giovanni Luca, Giulio Rossi, Francesco Agustoni, et al.. (2024). Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach. Critical Reviews in Oncology/Hematology. 199. 104247–104247. 1 indexed citations
5.
Colonese, Francesca, Alessandra Bulotta, Carlo Genova, et al.. (2024). Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge. Biomedicines. 12(12). 2742–2742.
6.
Canova, Stefania, Francesca Colonese, Luca Sala, et al.. (2023). Novel Therapeutic Options for Small Cell Lung Cancer. Current Oncology Reports. 25(11). 1277–1294. 10 indexed citations
7.
Putzu, Carlo, Stefania Canova, Panagiotis Paliogiannis, et al.. (2023). Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?. Cancers. 15(3). 689–689. 20 indexed citations
8.
Cuomo, Arturo, et al.. (2023). High-rate breakthrough cancer pain and tumour characteristics – literature review and case series. Drugs in Context. 12. 1–13. 5 indexed citations
9.
Cortinovis, Diego, Francesca Colonese, Luca Sala, et al.. (2022). Harnessing DLL3 inhibition: From old promises to new therapeutic horizons. Frontiers in Medicine. 9. 989405–989405. 7 indexed citations
10.
Cortinovis, Diego, Paolo Bidoli, Stefania Canova, et al.. (2021). Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma. Cancers. 13(5). 1152–1152. 10 indexed citations
11.
Gemelli, Maria, Paolo Bidoli, Francesca Colonese, Stefania Canova, & Diego Cortinovis. (2021). Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancer. Frontiers in Bioscience-Scholar. 13(2). 190–201. 2 indexed citations
12.
Cortinovis, Diego, Marcello Tiseo, Tiziana Vavalà, et al.. (2019). Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer: Retrospective Multicentric Analysis and Literature Review. Future Oncology. 15(9). 989–994. 11 indexed citations
13.
Banna, Giuseppe Luigi, Francesco Passiglia, Francesca Colonese, et al.. (2018). Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection. Critical Reviews in Oncology/Hematology. 129. 27–39. 33 indexed citations
14.
Putzu, Carlo, Diego Cortinovis, Francesca Colonese, et al.. (2018). Blood cell count indexes as predictors of outcomes in advanced non-small-cell lung cancer patients treated with Nivolumab. Cancer Immunology Immunotherapy. 67(9). 1349–1353. 61 indexed citations
15.
Cortinovis, Diego, et al.. (2018). Challenges in ALK Inhibition of ALK-Positive Non-Small-Cell Lung Cancer: from ALK Positivity Detection to Treatment Strategies After Relapse. Future Oncology. 14(22). 2303–2317. 6 indexed citations
16.
Cortinovis, Diego, et al.. (2016). Focus on Nivolumab in NSCLC. Frontiers in Medicine. 3. 67–67. 9 indexed citations
17.
Colonese, Francesca, Antonio Simone Laganà, Vincenza Sofo, et al.. (2015). The Pleiotropic Effects of Vitamin D in Gynaecological and Obstetric Diseases: An Overview on a Hot Topic. BioMed Research International. 2015. 1–11. 89 indexed citations
18.
Adamo, Vincenzo, Tindara Franchina, Paola Lucia Minciullo, et al.. (2011). Role of interleukin‐23 circulating levels increase in resected colorectal cancer before and after chemotherapy: Preliminary data and future perspectives. Journal of Cellular Physiology. 226(11). 3032–3034. 10 indexed citations
19.
Giuffrè, Giuseppe, Vincenzo Adamo, Antonio Ieni, et al.. (2011). Hematopoietic progenitor cells (HPCs) in node-negative invasive breast carcinomas: Immunohistochemical analysis and clinico-pathological correlations. Pathology - Research and Practice. 207(8). 487–491. 4 indexed citations
20.
Franchina, Tindara, Bárbara Adamo, Giuseppe Toscano, et al.. (2010). Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis.. Journal of Clinical Oncology. 28(15_suppl). e18110–e18110. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey Otton Breakdown of academic impact, for papers by Andrea Wahner Hendrickson Breakdown of academic impact, for papers by Xiaojie Fang Breakdown of academic impact, for papers by José Luis Alonso-Romero Breakdown of academic impact, for papers by Tomoko Hirakawa Breakdown of academic impact, for papers by Giusi Santangelo Breakdown of academic impact, for papers by Mary M. Mullen Breakdown of academic impact, for papers by Emily Prendergast Breakdown of academic impact, for papers by Tashanna Myers
Rankless by CCL
2026